Tumor Regression Grade
2 clinical trials · Condition
◉ Watch Tumor Regression Grade
| Record | Firm | Date |
|---|---|---|
| DLCS for Predicting Neoadjuvant Chemotherapy Response (NCT05617469) | Zhejiang Cancer Hospital | 2022-07-01 |
Track Tumor Regression Grade automatically
Every clearance here is in the API, with alerts when new ones post.